메뉴 건너뛰기




Volumn 188, Issue 9, 2003, Pages 1362-1366

Cross-Reactive H1N1 Antibody Responses to a Live Attenuated Influenza Vaccine in Children: Implication for Selection of Vaccine Strains

Author keywords

[No Author keywords available]

Indexed keywords

CROSS REACTING ANTIBODY; HEMAGGLUTINATION INHIBITING ANTIBODY; INFLUENZA VACCINE; LIVE VACCINE; TRIPLE VACCINE; VIRUS HEMAGGLUTININ;

EID: 0242721030     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/379045     Document Type: Article
Times cited : (24)

References (17)
  • 1
    • 0035918179 scopus 로고    scopus 로고
    • Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
    • Bridges CB, Fukuda K, Cox NJ, Singleton JA. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2001; 50:1-44.
    • (2001) MMWR Recomm Rep , vol.50 , pp. 1-44
    • Bridges, C.B.1    Fukuda, K.2    Cox, N.J.3    Singleton, J.A.4
  • 2
    • 0001903969 scopus 로고    scopus 로고
    • Inactivated influenza vaccines
    • Plotkin SA, Orenstein WA, eds. Philadelphia: W. B. Saunders
    • Kilbourne ED, Arden NH. Inactivated influenza vaccines. In: Plotkin SA, Orenstein WA, eds. Vaccines. 3rd ed. Philadelphia: W. B. Saunders, 1999:531-52.
    • (1999) Vaccines. 3rd Ed. , pp. 531-552
    • Kilbourne, E.D.1    Arden, N.H.2
  • 3
    • 0025246369 scopus 로고
    • Structural basis of immune recognition of influenza virus hemagglutinin
    • Wilson IA, Cox N. Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol 1990; 8:737-71.
    • (1990) Annu Rev Immunol , vol.8 , pp. 737-771
    • Wilson, I.A.1    Cox, N.2
  • 4
    • 0020416123 scopus 로고
    • The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype)
    • Caton AJ, Brownlee GG, Yewdell JW, Gerhard W. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 1982; 31:417-27.
    • (1982) Cell , vol.31 , pp. 417-427
    • Caton, A.J.1    Brownlee, G.G.2    Yewdell, J.W.3    Gerhard, W.4
  • 5
    • 0032516267 scopus 로고    scopus 로고
    • The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza vaccine in children
    • Belshe RB, Medelman PM, Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza vaccine in children. N Engl J Med 1998; 338:1405-12.
    • (1998) N Engl J Med , vol.338 , pp. 1405-1412
    • Belshe, R.B.1    Medelman, P.M.2    Treanor, J.3
  • 6
    • 0033913482 scopus 로고    scopus 로고
    • Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
    • Belshe RB, Gruber WC, Mendelman PM, et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr 2000; 136:168-75.
    • (2000) J Pediatr , vol.136 , pp. 168-175
    • Belshe, R.B.1    Gruber, W.C.2    Mendelman, P.M.3
  • 7
    • 0034083593 scopus 로고    scopus 로고
    • Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine
    • Belshe RB, Gruber WC, Mendelman PM, et al. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis 2000; 181:1133-7.
    • (2000) J Infect Dis , vol.181 , pp. 1133-1137
    • Belshe, R.B.1    Gruber, W.C.2    Mendelman, P.M.3
  • 8
    • 0034025857 scopus 로고    scopus 로고
    • Prevention of otitis media in children with live attenuated influenza vaccine given intranasally
    • Belshe RB, Gruber WC. Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatr Infect Dis J 2000; 19:S66-71.
    • (2000) Pediatr Infect Dis J , vol.19
    • Belshe, R.B.1    Gruber, W.C.2
  • 9
    • 0034881249 scopus 로고    scopus 로고
    • Prospective, randomized, placebo-controlled evaluation of the safety and immunogenicity of three lots of intranasal trivalent influenza vaccine among young children
    • Zangwill KM, Droge J, Mendelman P, et al. Prospective, randomized, placebo-controlled evaluation of the safety and immunogenicity of three lots of intranasal trivalent influenza vaccine among young children. Pediatr Infect Dis J 2001; 20:740-6.
    • (2001) Pediatr Infect Dis J , vol.20 , pp. 740-746
    • Zangwill, K.M.1    Droge, J.2    Mendelman, P.3
  • 10
    • 0035925590 scopus 로고    scopus 로고
    • Safety, efficacy and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults
    • Mendelman PM, Cordova J, Cho I. Safety, efficacy and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults. Vaccine 2001; 19:2221-6.
    • (2001) Vaccine , vol.19 , pp. 2221-2226
    • Mendelman, P.M.1    Cordova, J.2    Cho, I.3
  • 11
    • 0037424114 scopus 로고    scopus 로고
    • Safety and immunogenicity of a live-attenuated influenza vaccine blended and filled at two manufacturing facilities
    • Nolan T, Lee MS, Cordova JM, et al. Safety and immunogenicity of a live-attenuated influenza vaccine blended and filled at two manufacturing facilities. Vaccine 2003; 21:1224-31.
    • (2003) Vaccine , vol.21 , pp. 1224-1231
    • Nolan, T.1    Lee, M.S.2    Cordova, J.M.3
  • 12
    • 0002961564 scopus 로고    scopus 로고
    • Live influenza virus vaccine
    • Plotkin SA, Orenstein WA, eds. Philadelphia: W. B. Saunders
    • Maassab HF, Herlocher ML, Bryant ML. Live influenza virus vaccine. In: Plotkin SA, Orenstein WA, eds. Vaccines. 3rd ed. Philadelphia: W. B. Saunders, 1999:909-27.
    • (1999) Vaccines. 3rd Ed. , pp. 909-927
    • Maassab, H.F.1    Herlocher, M.L.2    Bryant, M.L.3
  • 14
    • 0031588673 scopus 로고    scopus 로고
    • Recommended composition of influenza virus vaccines
    • World Health Organization. Recommended composition of influenza virus vaccines. Wkly Epidemiol Rec 1997; 72:57-61; 1998; 73:56-61; 2000; 75:61-5.
    • (1997) Wkly Epidemiol Rec , vol.72 , pp. 57-61
  • 15
    • 0031588673 scopus 로고    scopus 로고
    • World Health Organization. Recommended composition of influenza virus vaccines. Wkly Epidemiol Rec 1997; 72:57-61; 1998; 73:56-61; 2000; 75:61-5.
    • (1998) Wkly Epidemiol Rec , vol.73 , pp. 56-61
  • 16
    • 0031588673 scopus 로고    scopus 로고
    • World Health Organization. Recommended composition of influenza virus vaccines. Wkly Epidemiol Rec 1997; 72:57-61; 1998; 73:56-61; 2000; 75:61-5.
    • (2000) Wkly Epidemiol Rec , vol.75 , pp. 61-65


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.